Home
Conditions
Malignant Lymphoma

Clinical trial condition

Malignant Lymphoma

Explore clinical trials studying Malignant Lymphoma. Study availability and eligibility vary by location and protocol.

19 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Malignant Lymphoma trial results

Completed

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

NCT01499147

Conditions: Acute Leukemia, Acute Myeloid Leukemia, Anemia, +51 more
Locations: University of Illinois at Chicago Medical Center Chicago, Illinois, United States

View Trial Details

Completed

Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma

NCT01473095

Conditions: Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +19 more
Locations: Birmingham, Alabama, United States

Scottsdale, Arizona, United States

Miami, Florida, United States

Atlanta, Georgia, United States

View Trial Details

Completed

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

NCT00683046

Conditions: Acute Myelogenous Leukemia, Anemia, Anemia, Aplastic, +41 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma

NCT01588548

Conditions: Advanced Solid Malignancies, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Research Site Chūōku, Japan

Research Site Manchester, United Kingdom

Research Site Surrey, United Kingdom

View Trial Details

Completed

Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?

NCT00892502

Conditions: Blood Diseases, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations: Department of Haematology L, Herlev Hospital, Herlev Ringvej 75 Herlev, Denmark

View Trial Details

Completed

Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas

NCT00685997

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +10 more
Locations: Academic Medical Center Amsterdam Amsterdam, North Holland, Netherlands

Meander Medical Center Amersfoort Amersfoort, Utrecht, Netherlands

University Medical Center Utrecht Utrecht, Netherlands

View Trial Details

Completed

p-AKT Expression on Clinical Outcomes in Malignant Lymphoma

NCT01789060

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Active, Not Recruiting

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis

NCT06475820

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +19 more
Locations: Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, Samory-Mashela,1, Russia

View Trial Details

Active, Not Recruiting

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis

NCT05515029

Conditions: Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia, Bone Marrow Diseases, +21 more
Locations: Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, Samory-Mashela,1, Russia

View Trial Details

Malignant Lymphoma

Malignant Lymphoma trial results

Related conditions